Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2025-12-25 @ 1:24 AM
NCT ID:
NCT01991093
Eligibility Criteria:
Inclusion Criteria:
* type 2 diabetes mellitus (T2DM)
* coronary artery disease (CAD)patients
* males and females
* patients who will be on clopidogrel treatment
* patients treated with prasugler or ticagrelor after an ACS will also undergo platelet reactivity tests, will be followed-up to record the primary endpoint for one year and will serve as control group to patients treated with clopidogrel
* patients who will sign the study informed consent form
* patients who will comply with all study procedures
Exclusion Criteria:
* patients who will not sign the study informed consent form
* patients who will not comply with all study procedures
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT01991093
Study Brief:
Protocol Section:
NCT01991093